Evidence-Based Medicine Guidelines
Primary hyperaldosteronism (PHA)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Primary Hyperaldosteronism (PHA)." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452591/all/Primary_hyperaldosteronism__PHA_.
Primary hyperaldosteronism (PHA). Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/452591/all/Primary_hyperaldosteronism__PHA_. Accessed October 27, 2024.
Primary hyperaldosteronism (PHA). (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/452591/all/Primary_hyperaldosteronism__PHA_
Primary Hyperaldosteronism (PHA) [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452591/all/Primary_hyperaldosteronism__PHA_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Primary hyperaldosteronism (PHA)
ID - 452591
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452591/all/Primary_hyperaldosteronism__PHA_
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
